C. David Wrede

3.3k total citations
52 papers, 1.6k citations indexed

About

C. David Wrede is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, C. David Wrede has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 22 papers in Oncology and 17 papers in Surgery. Recurrent topics in C. David Wrede's work include Cervical Cancer and HPV Research (38 papers), Genital Health and Disease (13 papers) and Global Cancer Incidence and Screening (11 papers). C. David Wrede is often cited by papers focused on Cervical Cancer and HPV Research (38 papers), Genital Health and Disease (13 papers) and Global Cancer Incidence and Screening (11 papers). C. David Wrede collaborates with scholars based in Australia, United States and United Kingdom. C. David Wrede's co-authors include Karen H. Vousden, Timothy Crook, John Tidy, Tim Crook, David J. Evans, W. P. Mason, Julia Brotherton, Marion Saville, Dorota M. Gertig and Farhana Sultana and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

C. David Wrede

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. David Wrede Australia	20	988	761	336	294	260	52	1.6k
Alice Lytwyn Canada	24	1.4k 1.4×	593 0.8×	226 0.7×	836 2.8×	282 1.1×	60	2.1k
Takuma Fujii Japan	25	785 0.8×	308 0.4×	448 1.3×	377 1.3×	417 1.6×	105	1.7k
Yin Ling Woo Malaysia	22	465 0.5×	388 0.5×	304 0.9×	221 0.8×	208 0.8×	58	1.3k
Nieves Ascunce Spain	27	1.3k 1.4×	1.1k 1.4×	175 0.5×	602 2.0×	197 0.8×	53	2.4k
Steinar Thoresen Norway	30	852 0.9×	980 1.3×	249 0.7×	512 1.7×	383 1.5×	49	2.4k
Freija Verdoodt Belgium	20	1.2k 1.2×	672 0.9×	283 0.8×	440 1.5×	233 0.9×	53	1.8k
P. Viladiu Spain	12	874 0.9×	355 0.5×	253 0.8×	374 1.3×	163 0.6×	20	1.4k
Michael Conner United States	23	469 0.5×	521 0.7×	489 1.5×	222 0.8×	448 1.7×	72	1.9k
Inger Gustavsson Sweden	19	888 0.9×	238 0.3×	360 1.1×	341 1.2×	232 0.9×	44	1.3k
Thomas Ehlen Canada	19	663 0.7×	248 0.3×	306 0.9×	329 1.1×	171 0.7×	35	1.5k

Countries citing papers authored by C. David Wrede

Since Specialization

Citations

This map shows the geographic impact of C. David Wrede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. David Wrede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. David Wrede more than expected).

Fields of papers citing papers by C. David Wrede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. David Wrede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. David Wrede. The network helps show where C. David Wrede may publish in the future.

Co-authorship network of co-authors of C. David Wrede

This figure shows the co-authorship network connecting the top 25 collaborators of C. David Wrede. A scholar is included among the top collaborators of C. David Wrede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. David Wrede. C. David Wrede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hall, Michaela, Michael Caruana, Louiza S. Velentzis, et al.. (2025). Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening. Vaccine. 54. 126986–126986. 1 indexed citations

Price, Sarah, Sue Finch, Efrosinia O. Krejany, et al.. (2023). WHAM—A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomy. The Journal of Clinical Endocrinology & Metabolism. 109(1). e397–e405. 2 indexed citations

Sultana, Farhana, Dorota M. Gertig, Dallas R. English, et al.. (2022). HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial. Journal of Medical Screening. 29(3). 185–193. 8 indexed citations

Velentzis, Louiza S., Megan A. Smith, Sam Egger, et al.. (2021). The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes. Human Vaccines & Immunotherapeutics. 17(10). 3562–3576. 9 indexed citations

Wrede, C. David, et al.. (2021). Primary HPV cervical screening: Clinical audit of outcomes of women seen at a tertiary referral centre for colposcopy in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 61(5). 750–758. 2 indexed citations

Hickey, Martha, Katrina M. Moss, Alison H. Brand, et al.. (2021). What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. Gynecologic Oncology. 161(2). 527–534. 19 indexed citations

Saville, Marion, David Hawkes, Farhana Sultana, et al.. (2020). Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study. Journal of Clinical Virology. 127. 104375–104375. 38 indexed citations

Egger, Sam, Megan A. Smith, Louiza S. Velentzis, et al.. (2020). Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia. The Journal of Infectious Diseases. 222(3). 499–508. 19 indexed citations

Foster, Emma, Michael J. Malloy, Vilija Jokubaitis, et al.. (2020). Increased risk of cervical dysplasia in females with autoimmune conditions—Results from an Australia database linkage study. PLoS ONE. 15(6). e0234813–e0234813. 17 indexed citations

10.

Hickey, Martha, et al.. (2019). What information do healthcare professionals need to inform premenopausal women about risk-reducing salpingo-oophorectomy?. Menopause The Journal of The North American Menopause Society. 27(1). 20–25. 8 indexed citations

11.

Hickey, Martha, et al.. (2019). Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women. Menopause The Journal of The North American Menopause Society. 27(1). 26–32. 21 indexed citations

12.

Goergen, Stacy, et al.. (2018). Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders. Clinical Radiology. 73(10). 908.e1–908.e9. 21 indexed citations

13.

Canfell, Karen, Michael Caruana, Val Gebski, et al.. (2017). Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Medicine. 14(9). e1002388–e1002388. 62 indexed citations

14.

Kentwell, Maira, Yoland Antill, C. David Wrede, et al.. (2017). Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecologic Oncology. 145(1). 130–136. 80 indexed citations

15.

Sultana, Farhana, Dallas R. English, J. A. Simpson, et al.. (2014). Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia. BMC Cancer. 14(1). 207–207. 24 indexed citations

16.

Tabrizi, Sepehr N., Julia Brotherton, Alyssa M. Cornall, et al.. (2014). Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program. Vaccine. 33(1). 201–208. 48 indexed citations

17.

Tabrizi, Sepehr N., Julia Brotherton, John D. Wark, et al.. (2013). Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study). BMC Cancer. 13(1). 296–296. 19 indexed citations

18.

Brand, Alison H., Thomas W. Jobling, Martin K. Oehler, et al.. (2012). Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial. The HKU Scholars Hub (University of Hong Kong). 26 indexed citations

19.

Brand, Alison H., Thomas W. Jobling, Marcelo Nascimento, et al.. (2012). Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial. The HKU Scholars Hub (University of Hong Kong). 84 indexed citations

20.

Wrede, C. David, et al.. (1992). Absence of HPV 16 and 18 DNA in breast cancer. British Journal of Cancer. 65(6). 891–894. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact